Lisa Nolan

Dr. Nolan joined Gossamer Bio in October 2019 as Managing Director and President, Gossamer Bio Ireland, where she is responsible for the leadership of the company’s ex-US operations based in Dublin, Ireland. Prior to joining Gossamer, she served as Chief Business Officer for several public and private biotech companies in the US & Canada including Rexahn Pharmaceuticals, Relmada Therapeutics, and Topigen. She has also held senior positions in business development and strategic marketing with Skyepharma and with West Pharmaceutical Services. She spent her early career with Elan Corporation and with Zeneca Pharmaceuticals in Europe where she served in broad-ranging roles in clinical research, regulatory, and various commercial roles. Dr. Nolan holds an M.Sc. in pharmacy and a Ph.D. in clinical pharmacology from Trinity College, Dublin.